Bharat Biotech | The Asian Age

Thursday, Apr 25, 2024 | Last Update : 05:24 PM IST

bharat biotech Page-2

A health worker carries vials of the Covaxin vaccine against the Covid-19 coronavirus at a health centre in New Dehi. (Photo: AFP)

WHO assessing Covaxin data for EUL; Decision date 'to be confirmed'

Rolling data allows the WHO to start its review right away to accelerate the overall review process

20 Jul 2021 10:49 AM

People sit in the observation area after being inoculated with a dose of the Covaxin vaccine against the Covid-19 coronavirus at a vaccination centre in Manipal Hospital in Bangalore on June 18, 2021. (Manjunath Kiran / AFP)

Will receive EUL for Covaxin from WHO at earliest, says Bharat Biotech

The indigenous vaccine showed 63.6 per cent efficacy against the Delta variant of Covid-19

13 Jul 2021 8:36 AM

At present, the WHO has approved vaccines by Pfizer/BioNTech, Astrazeneca-SK Bio/Serum Institute of India, AstraZeneca EU, Janssen, Moderna and Sinopharm for emergency use. (PTI Photo)

Decision on emergency use listing of Covaxin likely in 4-6 weeks: WHO

Swaminathan said WHO is reviewing Covaxin as its manufacturer Bharat Biotech is now uploading its entire data on the health body's portal

10 Jul 2021 5:01 PM

Phase 3 clinical trials of the vaccine was an event driven analysis of 130 symptomatic COVID-19 cases, reported at least two weeks after the second dose, conducted at 25 sites across India. (PTI)

Final analysis of Covaxin efficacy out; 65.2 per cent effective against Delta

The efficacy analysis demonstrates Covaxin to be 93.4 per cent effective against severe symptomatic COVID-19 cases

03 Jul 2021 10:50 AM

The deal to buy 20 million doses of Bharat Biotech's Covaxin shot has become a headache for Bolsonaro after whistleblowers went public with alleged irregularities. (AFP)

Brazil to suspend Indian COVID-19 vaccine deal as graft allegations probed

Brazilian federal prosecutors have opened an investigation into the deal, citing comparatively high prices and pending regulatory approvals

30 Jun 2021 10:41 AM

A medic holds a vial of Bharat Biotech's covid vaccine, Covaxin. (Photo: AFP)

Bharat Biotech says supply price of Covaxin to Centre at Rs 150 not viable

The manufacturer said it had so far invested over Rs 500 crore 'from its own resources'

15 Jun 2021 4:36 PM

The AstraZeneca/Oxford COVID-19 vaccine got its approvals on February 15. (Photo: PTI)

Bharat Biotech says EUL for COVAXIN submitted to WHO, approval expected by July-Sept

The WHO has given approvals to the Pfizer/BioNTech vaccine for emergency use on December 31

26 May 2021 10:37 AM

Govt ready to allow other companies to make Covaxin

The government has now engaged five Public Sector Undertakings to help increase production of Covaxin

14 May 2021 12:00 AM

The deputy CM urged the Centre to stop all vaccine-related exports and allow more companies to produce doses. — DC file photo

Delhi blames Bharat Bio for vaccine shortage

Sisodia says pharma firm refused to supply required doses after reserve stock of vaccines exhausted

13 May 2021 6:59 AM

There is no clarity among the officials of both the Telugu states on whether they can import vaccines directly from the manufacturers in other countries or wait for approval from the relevant Central agencies. — Representational image/PTI

States rushing for global vaccine tenders

The officials took the cue from the Uttar Pradesh government, ruled by BJP, which was first among the states to moot global tenders

12 May 2021 8:15 AM

The phase 3 of vaccination will begin amid concerns of vaccine shortage as states like Maharashtra are short of vaccines and may not begin the vaccination drive for the 18-45 age group on Saturday. (AP)

Serum Institute cuts vaccine price for states to Rs 300/dose

Bharat Biotech which priced its Covaxin shots at ₹600 for states and ₹1,200 for private hospitals is yet to announce the price cut

29 Apr 2021 1:00 AM

Dr. Anthony Fauci, director of the National Institute for Allergy and Infectious Diseases. (AP)

India's Covaxin found to neutralise 617 variant of COVID-19: Dr Fauci

'So, despite the real difficulty that we're seeing in India, vaccination could be a very, very important antidote against this,' Fauci added

28 Apr 2021 1:24 PM

View of a vial of India's COVAXIN vaccine against COVID-19. (AFP)

COVAXIN effective against multiple variants of SARS-COV-2, double mutant strain: ICMR

This development comes amid the second wave of the COVID-19 pandemic being witnessed across the country

21 Apr 2021 1:47 PM

During his brief stay at the hospital, the PM chatted with the nurses and other staff and even cracked jokes with them. — PTI

Modi takes first dose of indigenously made Covaxin at AIIMS

The decision to take the Covaxin shot by the PM was intended to quell the apprehensions and suspicion over the India-made vaccine

02 Mar 2021 8:26 AM

The real motivation here is actually exfiltrating intellectual property and getting competitive advantage over Indian pharmaceutical companies. — PTI

Chinese hackers target Indian vaccine makers

Chinese hacking group APT10, also known as Stone Panda, identified gaps in the IT infra and supply chain software of Bharat Biotech and SII

02 Mar 2021 8:00 AM

A file photo of the doctors from Osmania General Hospital who were vaccinated ( Image Source: DC Image)

Transparency needed to remove all vaccine fears

Frankly, it’s not just bizarre but deplorable to frame differences over the efficacy of Covaxin as issues of national pride

22 Jan 2021 6:36 AM

A health worker receives a COVID-19 vaccine at a government Hospital in Mumbai, India. (AP)

Centre issues Letter of Comfort to Bharat Biotech for 45 lakh doses of Covaxin

The Hyderabad-based vaccine maker will be supplying over eight lakh doses of Covaxin to some of the friendly countries free of cost

19 Jan 2021 3:43 PM

In a letter to the PM, 4 NGOs comprising Bhopal gas tragedy survivors have asked to halt the ongoing trial of Covaxin. (Representational Image/AFP)

Bhopal gas tragedy survivors demand halt to ‘unethical’ vaccine trial

The NGOs allege that the consent procedure and other protocol of testing are being thrown to winds

11 Jan 2021 4:56 AM

India has authorised the emergency use of two coronavirus vaccines developed by AstraZeneca and Oxford University and by local pharmaceutical firm Bharat Biotech, the country's drug regulator said Sunday. (Representational Image: PTI)

DCGI approves two Covid-19 vaccines for emergency use

The approval is expected to kick off one of the world's biggest vaccination drives in coming days in the country of 1.3 billion people

03 Jan 2021 11:54 AM

A medic administers Covaxin, developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), during the Phase- 3 trials at the People's Medical College in Bhopal, Monday, Dec. 7, 2020. (PTI)

DCGI denies EUA to Covid vaccines shots of Bharat Biotech, Serum

‘Expert panels seeks more data on efficiency, safety’

09 Dec 2020 11:36 PM

2 of 3

Columns

Dilip Cherian